Marinus Verwijs - 21 Mar 2022 Form 3 Insider Report for Aerovate Therapeutics, Inc. (JBIO)

Role: Senior Vice President, CMC
Signature: /s/ George A. Eldridge, Attorney-in-Fact
Issuer symbol: JBIO
Transactions as of: 21 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 23 Mar 2022, 07:45:26 UTC
Next filing: 03 Nov 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney